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ConclusionsBackground and Hypothesis
Human Mesenchymal Stem Cells: Human
mesenchymal stem cells (hMSCs) are a multipotent cell, meaning
they are able to differentiate into a more mature cell type, such as
osteocytes, chondrocytes, and adipocytes, that are found in
numerous tissues in the human body, such as bone marrow, fat,
and muscle. Since hMSCs can be derived from adult human
tissues, they do not have the same ethical concern associated
with them as other stem cells, such as embryonic stem cells. Due
to hMSCs multipotency and ease of obtaining, they have become
one of the most widely researched stem cell types in areas such
as tissue engineering and regenerative medicine, targeted
delivery of drugs/secretion of therapeutic proteins, and cancer
therapy1.
Nonviral Gene Delivery: Nonviral gene delivery is the
transfer of exogenous genetic material (e.g. plasmid DNA, siRNA)
to cells using a nonviral vector, typically a cationic lipid or polymer.
While nonviral delivery systems are considered safer than viral
delivery systems, nonviral gene delivery suffers from low
transfection efficiencies, especially in hMSCS, which limits its
therapeutic potential. Our lab has previously shown that priming
hMSCs with the glucocorticoid (GC) dexamethasone (DEX) 0-30
minutes prior to transfection can increase transgene expression
by as much as 13 fold in hMSCs derived from numerous donors
and tissues1.
Hypothesis: We hypothesize that physical and chemical
priming of hMSCs prior to and during nonviral gene delivery
can elicit a tailored response (i.e. activation of signaling
pathways, increased proliferation, integrin clustering) that can
alter the transfection outcomes in hMSCs.
All transfection studies were performed using reporter plasmid encoding for a
green fluorescent and luciferase fusion protein driven by a cytomegalovirus
(CMV) promoter, and complexed with Lipofectamine (Invitrogen) lipid
transfection reagents. Luciferase assay (Promega) was used to quantify
transfection in relative light units, normalized to total protein. Adipose derived
mesenchymal stem cells (AMSCs) and bone marrow derived mesenchymal stem
cells (BMSCs) between passages 2 and 7 were used in all studies.
AMSCs Cultured on SCTFs Show Increased Transgene 
Expression for Bolus Delivery of Lipoplexes
Substrate Mediated Delivery (SMD) Shows Increase in Fold Change 
(DEX+/DEX-) for hMSCs cultured on SCTFs
Glancing Angle Deposition (GLAD)2
Figure 2: (A) Physical priming of
hMSCs was achieved by culturing on
titanium (Ti) sculptured thin films
(STFs) formed by GLAD. (B) STFs
used were slanted columnar thin
films (SCTFs), vertical columnar thin
films (VCTF), pre-nucleated slanted
columnar thin films (pnSCTFs), and
flat Ti. Chemical priming of hMSCs
was achieved by addition of DEX to
the culture media.
Transfection of hMSCs
Figure 4: (A) A 3 fold increase in transgene expression, compared
to both polystyrene (PS) and flat Ti, is seen for AMSCs cultured on
SCTFs prior to bolus delivery of lipoplexes. (B) BMSCs do not see
the same increase, suggesting physical cues from the substrate are
interpreted differently by each stem cell type.
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Figure 5: (A,B) Although transgene
expression is increased for all STFs with
the addition of DEX, (A) a synergistic
effect is not seen when DEX is added to
AMSCs cultured on SCTFs
• SCTFs increase transgene expression in AMSCs
receiving bolus delivery of lipoplexes.
‐ Similar results are not seen in BMSCs
cultured on SCTFs, suggesting
physical cues are interpreted
differently by hMSCs derived from
different tissues.
• DEX increases transgene expression in AMSCs
cultured on STFs, but does not add to increase
seen in SCTF cultured AMSCs.
• SMD requires ¼ of the plasmid DNA and ½ of the
complexing agent compared to bolus.
• AMSCs cultured on SCTFs show a significantly
higher fold increase (DEX+/DEX-) in transgene
expression for lipoplexes delivered via SMD.
• Fully characterize genotype of hMSCs cultured on
STFs to identify key genes and their effects on
transfection of hMSCs.
• Use photolithography techniques to create substrates
with nano- and micro-scale features.
• Optimize lipoplex loading onto STFs and DEX timing
for SMD studies.
• Research other areas of interest for STFs, such as
hMSCs differentiation, drug loading, and bactericidal
properties.
Figure 7: Different combinations of DNA concentration
(0.05-1.5 µg/well) and DNA to lipid ratios (1:1, 1:2, 1:3)
were tested to optimize SMD of lipoplexes to hMSCs. The
graph demonstrates that lower DNA concentration paired
with lower DNA to lipid ratios work best for SMD of
lipoplexes to hMSCs.
Figure 8: (A) Both physical and chemical priming of AMSCs
lead to a significantly higher fold increase (DEX+/DEX-) in transgene expression for SMD of lipoplexes.
BMSCs also show a increase in transgene expression for SMD of lipoplexes.
Increasing pDNA Concentration
Increasing Lipid Ratio
Figure 3: Schematic for bolus delivery of 
lipoplexes to hMSCs cultured on STFs.
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Figure 6: Schematic for SMD of lipoplexes to hMSCs cultured 
on STFs.
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Figure 1: (A,C) Enhanced transgene expression in BMSCs from DEX. (B) Molecular
structure of dexamethasone.
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